CARR vs NMRA · P/E 43, rev $21.75B vs $283.5M cap
Carrier Global Corp (CARR) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported CARR revenue for 2025-12-31 was $21.75B. Net income was $1.48B. Revenue was up 322.4% from 2024-12-31 to 2025-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
NMRA does not have a complete income-statement cache yet.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the CARR and NMRA stock pages for the full models.
Not investment advice.